Clinical Trial Update: Betaine vs. Placebo for Serologically Diagnosed Metabolic Dysfunction-associated Steatohepatitis (MASH) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing betaine to placebo for serologically diagnosed metabolic dysfunction-associated steatohepatitis (MASH); the study is not yet re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Steatohepatitis

Drugs mentioned

• Betaine (betaine (trimethylglycine))

Snippet

Sponsor: Southern California Institute for Research and Education | Conditions: MASH - Metabolic Dysfunction-Associated Steatohepatitis | Phase 2 | Status: NOT_YET_RECRUITING